volume 19 issue 16 pages 3589-3594

Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses

Tao Sun 1, 2, 3, 4, 5
Shijun He 5, 6, 7, 8, 9, 10, 11
Zhongliang Xu 5, 6, 8, 9, 10, 11
Jian-ping Zuo 6, 7
Jianping Zuo 5, 8, 9, 10, 11
Yang Yu 1, 2, 3, 4, 5
Weibo Yang 5, 6, 7, 8, 9, 10, 11, 12
Publication typeJournal Article
Publication date2021-03-24
scimago Q2
wos Q2
SJR0.600
CiteScore5.2
Impact factor2.7
ISSN14770520, 14770539
PubMed ID:  33908550
Organic Chemistry
Biochemistry
Physical and Theoretical Chemistry
Abstract
Inspired by aspirin and chalcone, herein, we describe a modular biomimetic strategy to achieve a new class of CF3-bearing benzannulated macrolactams. The key to the success of macrolactams was the utilization of a highly chemoselective Rh(iii)-catalyzed native carboxylic acid-directed C-H alkylation. Moreover, the unique CF3-containing benzannulated macrocycles showed decent immunosuppressive effects on B cells in vitro, including proliferation, activation, and antibody production upon specific stimulation implicating TLR and BCR signaling.
Found 
Found 

Top-30

Journals

1
Chem
1 publication, 12.5%
Angewandte Chemie - International Edition
1 publication, 12.5%
Angewandte Chemie
1 publication, 12.5%
Journal of Organic Chemistry
1 publication, 12.5%
European Journal of Organic Chemistry
1 publication, 12.5%
Journal of Materials Chemistry B
1 publication, 12.5%
Organic and Biomolecular Chemistry
1 publication, 12.5%
Organic Letters
1 publication, 12.5%
1

Publishers

1
2
3
Wiley
3 publications, 37.5%
American Chemical Society (ACS)
2 publications, 25%
Royal Society of Chemistry (RSC)
2 publications, 25%
Elsevier
1 publication, 12.5%
1
2
3
  • We do not take into account publications without a DOI.
  • Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
8
Share
Cite this
GOST |
Cite this
GOST Copy
Sun T. et al. Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses // Organic and Biomolecular Chemistry. 2021. Vol. 19. No. 16. pp. 3589-3594.
GOST all authors (up to 50) Copy
Sun T., He S., Xu Z., Zuo J., Zuo J., Yu Y., Yang W. Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses // Organic and Biomolecular Chemistry. 2021. Vol. 19. No. 16. pp. 3589-3594.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1039/d1ob00296a
UR - https://xlink.rsc.org/?DOI=D1OB00296A
TI - Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses
T2 - Organic and Biomolecular Chemistry
AU - Sun, Tao
AU - He, Shijun
AU - Xu, Zhongliang
AU - Zuo, Jian-ping
AU - Zuo, Jianping
AU - Yu, Yang
AU - Yang, Weibo
PY - 2021
DA - 2021/03/24
PB - Royal Society of Chemistry (RSC)
SP - 3589-3594
IS - 16
VL - 19
PMID - 33908550
SN - 1477-0520
SN - 1477-0539
ER -
BibTex |
Cite this
BibTex (up to 50 authors) Copy
@article{2021_Sun,
author = {Tao Sun and Shijun He and Zhongliang Xu and Jian-ping Zuo and Jianping Zuo and Yang Yu and Weibo Yang},
title = {Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses},
journal = {Organic and Biomolecular Chemistry},
year = {2021},
volume = {19},
publisher = {Royal Society of Chemistry (RSC)},
month = {mar},
url = {https://xlink.rsc.org/?DOI=D1OB00296A},
number = {16},
pages = {3589--3594},
doi = {10.1039/d1ob00296a}
}
MLA
Cite this
MLA Copy
Sun, Tao, et al. “Rh-Catalyzed C–H alkylation enabling modular synthesis of CF3-substituted benzannulated macrocyclic inhibitors of B cell responses.” Organic and Biomolecular Chemistry, vol. 19, no. 16, Mar. 2021, pp. 3589-3594. https://xlink.rsc.org/?DOI=D1OB00296A.
Profiles